Now awarded ISO 9001:2015 Certification for Quality Management System
As an organization, denovoMATRIX is driven by the undertaking of continuous improvement of our quality management system, a commitment to unremitting development of our staff and the fostering of customer relationships. denovoMATRIX GmbH is pleased to announce its ISO 9001:2015 Quality Management Standard certification by TÜV Süd.
The decision to work towards ISO 9001:2015 accreditation demonstrates commitment to continually improving their products and services. Gaining ISO 9001:2015 reinforces denovoMATRIX’ focus on offering solutions for the key challenges in manufacturing cell-based therapies, measured against global benchmarks of industry excellence.
‘’We are glad to pass this key milestone in our development pipeline. The certification is a testimony to the high level of commitment of the denovoMATRIX team to provide products and services to our customers satisfaction’’ explains the CSO of denovoMATRIX, Dr. Richard Wetzel.
CEO of denovoMATRIX Dr. Dejan Hušman commented, ‘’We are moving ever closer to our vision, with this certification removing barriers to our progress towards the implementation of our products in stem cell manufacturing for clinical use’’.
denovoMATRIX GmbH currently offers ready-to-use solutions for the expansion of stem cells with their screenMATRIX and myMATRIX MSC product lines as well as contract research services related to their biomaterial platform.
About denovoMATRIX GmbH
denovoMATRIX is an extracellular matrix engineering company that enables the acceleration of cell based therapies and development in stem cell research. The company leverages chemical synthesis, stem cell biology and design thinking to build a platform of biomaterials which address major life science challenges. By providing both cell based therapy companies and academic researchers with solutions, denovoMATRIX is at the forefront of innovation in biomaterials.